Description: The National Institutes of Health, through NIDA, seeks genomic laboratory and bioinformatics services for pharmacogenomic analysis of biospecimens from participants in STAR-B, a randomized clinical trial of semaglutide for alcohol use disorder. Work includes specimen receipt and tracking, DNA extraction and quality control, genome-wide genotyping and/or sequencing, bioinformatic processing, and delivery of raw, processed, annotated, and documented data. The special notice identifies Baltimore, Maryland as the place of performance, provides a 12-month period of performance, and requests responses by September 15, 2026 at 3:00 p.m. EDT.
Federal · MD, US
Original attachments and procurement documents tied to this bid.
Federal RFP files are for Starbridge customers only.
You can request RFP files from all other buyer types for free on this site.
Decision makers connected to this RFP from National Institutes of Health NIDA.
Adjacent opportunities open for bidding right now.
National Institutes of Health Niaid
FederalMD
Posted
Sep 8, 2026
Sep 15, 2026
Pharmacogenomic analysis of participants enrolled in the STAR-B randomized clinical trial of semaglutide for alcohol use disorder.
Posted
-
Oct 16, 2026
The Maryland Department of Public Safety and Correctional Services is seeking a contractor to provide comprehensive substance use disorder treatment services, including medication for opioid use disorder counseling, screening, assessment, therapy, care coordination, and re-entry planning. Services will be provided at multiple Baltimore City pre-trial detention facilities under an indefinite-quantity, fixed-unit-price agreement with a three-year base period and two optional two-year extensions. The solicitation requires electronic double-envelope submission through eMMA and includes a pre-proposal conference and site visit scheduled for September 11, 2026, with proposals due October 16, 2026.
Posted
-
Oct 16, 2026
The Maryland Department of Public Safety and Correctional Services is seeking a contractor to provide comprehensive substance use disorder treatment services, including medication for opioid use disorder counseling, screening, assessment, therapy, care coordination, and re-entry planning. Services will be provided at multiple Baltimore City pre-trial detention facilities under an indefinite-quantity, fixed-unit-price agreement with a three-year base period and two optional two-year extensions. The solicitation requires electronic double-envelope submission through eMMA and includes a pre-proposal conference and site visit scheduled for September 11, 2026, with proposals due October 16, 2026.
Detroit Wayne County Health Authority
Special DistrictMI
Posted
Aug 25, 2022
Jun 1, 2027
Substance use disorder treatment.
